EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer

Fabián Pitoia, Robert J Marlowe, Erika Abelleira, Eduardo N Faure, Fernanda Bueno, Diego Schwarzstein, Rubén Julio Lutfi, Hugo Niepomniszcze

Journal of Thyroid Research · 2012

DOI: 10.1155/2012/481568 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thyroid Research, 2012. Verfasst von Fabián Pitoia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Hospital de Clínicas, University of Buenos Aires, Córdoba 2351, 5th Floor, Buenos Aires 1424, Argentina. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Genzyme.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To supplement limited relevant literature, we retrospectively compared ablation and disease outcomes in high-risk differentiated thyroid carcinoma (DTC) patients undergoing radioiodine thyroid remnant ablation aided by recombinant human thyrotropin (rhTSH) versus thyroid hormone withdrawal/withholding (THW). Our cohort was 45 consecutive antithyroglobulin antibody- (TgAb-) negative, T3-T4/N0-N1-Nx/M0 adults ablated with high activities at three referral centers. Ablation success comprised negative (

Autor:innen und Institutionen

  • Division of Endocrinology, Hospital de Clínicas, University of Buenos Aires, Córdoba 2351, 5th Floor, Buenos Aires 1424, Argentina.

Förderung

  • Genzyme

Zitieren

APA

Pitoia, F., Marlowe, R. J., Abelleira, E., Faure, E. N., Bueno, F., Schwarzstein, D., Lutfi, R. J., & Niepomniszcze, H. (2012). Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer. Journal of Thyroid Research. https://doi.org/10.1155/2012/481568

Vancouver

Pitoia F, Marlowe RJ, Abelleira E, Faure EN, Bueno F, Schwarzstein D, et al. Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer. Journal of Thyroid Research. 2012. doi:10.1155/2012/481568

BibTeX
@article{Pitoia2012,
  author = {Pitoia, Fabián and Marlowe, Robert J and Abelleira, Erika and Faure, Eduardo N and Bueno, Fernanda and Schwarzstein, Diego and Lutfi, Rubén Julio and Niepomniszcze, Hugo},
  title = {Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer},
  journal = {Journal of Thyroid Research},
  year = {2012},
  doi = {10.1155/2012/481568}
}
Kostenlos starten →